This is not a Wikipedia article: It is an individual user's work-in-progress page, and may be incomplete and/or unreliable. For guidance on developing this draft, see Wikipedia:So you made a userspace draft.  Find sources:  Google ( books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL Easy tools: Citation bot ( help) | Advanced: Fix bare URLs This page was last edited by Ricky81682 ( talk | contribs) 8 years ago. ( Update timer) Finished writing a draft article? Are you ready to request an experienced editor review it for possible inclusion in Wikipedia?     Submit your draft for review!

Pan-Canadian Pharmaceutical Alliance PCPA established in August 2010, by Premiers through the the Council of the Federation (COF). "The PCPA is a pan-Canadian initiative consisting of the following jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, Prince Edward Island, Saskatchewan, and the Yukon. These jurisdictions conduct joint negotiations for brand name drug products being considered for reimbursement through their respective public drug plans. This approach is intended to capitalize on the combined purchasing power of public drug plans across multiple jurisdictions, improve the consistency of drug listing decisions across the country, ensure benefits are cost effective, and increase access to drug treatment options." ^[1] The Office was established September 30, 2014 by Canadian provincial and territorial Health Ministers to support the work of the pan-Canadian Pharmaceutical Alliance (pCPA). The decision to establish an Office of the pCPA (Office) was informed by the work completed by In 2014 IBM Canada Ltd published a report based on "reviews of international practices and broad consultation with both internal and external stakeholders." ^[2]

References